thematicstraightflushcards: Positive factors boost the "Red May" expectation that the market is expected to fluctuate upwards

On May 7, it was reported that the concept of synthetic biology rose again in intraday trading, with Tuoxin Pharmaceutical trading at a daily limit of 20CM. Previously, Fujiilai had three consecutive boards, Guangji Pharmaceutical had two consecutive boards, and Garden Biology, Xinghu Technology, Langkun Environment, Chuanning Biology, Lukang Pharmaceutical, etc. followed suit.

On the news front, according to McKinsey estimates, synthetic biology will generate US$2 trillion to US$4 trillion in the future in four major areas: materials, chemicals and energy, human health and performance, agriculture, aquaculture and food, and consumer goods and services. Economic impact.